Controlled Pharmacodynamics with Melanin Targeted Drug Delivery to the Eye
Bidragets beskrivning
Ocular diseases are common and growing problem that endangers the vision of millions of patients. Drug treatment of glaucoma is accomplished with frequently applied eye drops that are difficult to use, leading to poor patient compliance. In age-related macular degeneration the medications are given as direct injections to the eye, but this is burdensome to patients and healthcare. This project aims to develop long acting therapeutics that are based on drug binding to melanin pigment in the eye. New compounds will be designed, synthesized and tested. Furthermore, computational models are developed to facilitate the development of long-acting ocular injections and eye drops for the treatment of glaucoma and age-related macular degeneration.
Visa merStartår
2021
Slutår
2023
Beviljade finansiering
Övriga uppgifter
Finansieringsbeslutets nummer
343138
Vetenskapsområden
Farmaci
Forskningsområden
Farmasia
Identifierade teman
eyes, eye diseases